In 2021, the Chinese Center for Drug Evaluation of the National Medical Products Administration (NMPA) approved 149 New Drug Applications (NDA) for biopharmaceuticals. 40 percent of all approvals were granted to antineoplastic drugs, while biopharmaceuticals for the treatment of blood system and endocrine system diseases were also prevalent among the approvals.
Distribution of therapeutic areas for approved biopharmaceutical New Drug Applications (NDA) in China in 2021
Characteristic
Number of approved applications
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
National Medical Products Administration. (June 1, 2022). Distribution of therapeutic areas for approved biopharmaceutical New Drug Applications (NDA) in China in 2021 [Graph]. In Statista. Retrieved September 01, 2024, from https://www.statista.com/statistics/1319964/china-therapeutic-for-approved-biopharmaceutical-nda/
National Medical Products Administration. "Distribution of therapeutic areas for approved biopharmaceutical New Drug Applications (NDA) in China in 2021." Chart. June 1, 2022. Statista. Accessed September 01, 2024. https://www.statista.com/statistics/1319964/china-therapeutic-for-approved-biopharmaceutical-nda/
National Medical Products Administration. (2022). Distribution of therapeutic areas for approved biopharmaceutical New Drug Applications (NDA) in China in 2021. Statista. Statista Inc.. Accessed: September 01, 2024. https://www.statista.com/statistics/1319964/china-therapeutic-for-approved-biopharmaceutical-nda/
National Medical Products Administration. "Distribution of Therapeutic Areas for Approved Biopharmaceutical New Drug Applications (Nda) in China in 2021." Statista, Statista Inc., 1 Jun 2022, https://www.statista.com/statistics/1319964/china-therapeutic-for-approved-biopharmaceutical-nda/
National Medical Products Administration, Distribution of therapeutic areas for approved biopharmaceutical New Drug Applications (NDA) in China in 2021 Statista, https://www.statista.com/statistics/1319964/china-therapeutic-for-approved-biopharmaceutical-nda/ (last visited September 01, 2024)
Distribution of therapeutic areas for approved biopharmaceutical New Drug Applications (NDA) in China in 2021 [Graph], National Medical Products Administration, June 1, 2022. [Online]. Available: https://www.statista.com/statistics/1319964/china-therapeutic-for-approved-biopharmaceutical-nda/